BSECompany Update7 Aug 2026 · 7 Aug 2026, 07:00 pm
Intimation of Schedule of Analyst / Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Tatva Chintan Pharma Chem Ltd · 543321
✦ AI Summary
Tatva Chintan Pharma Chem Ltd has announced a schedule of analyst/investor meetings, which will be held on August 12, 2026, with Ambit Global Private and TA Associate. The meetings will be virtual and will not include any confidential or unpublished price-sensitive information.
Analysis Scores
Earnings Impact0/10
Growth Catalyst0/10
Governance Concern0/10
Regulatory Risk0/10
Balance Sheet Risk0/10
Liquidity Impact0/10
Market Sentiment0/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Tatva Chintan Pharma Chem Ltd - 543321 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Attachments (1)
📄pdf
Download →
0e0cdacd-cabe-460d-a747-c5f5209fcf31.pdf
View document text
Date:07August 2026 Ref.No.:TCPCL/SEC/2026-27/00034
TheGeneralManager, TheManager,
Corporaterelationshipdepartment, Listingdepartment,
BSELimited NationalStockExchangeofIndiaLimited
PhirozeJeejeebhoyTowers, ExchangePlaza,C-1,Block-G,
DalalStreet,Fort, Bandra-KurlaComplex,Bandra(E),
Mumbai-400001 Mumbai-400051
ScripCode:543321 ScripSymbol:TATVA
Subject:IntimationofScheduleofAnalyst(s)/Financial Institution(s)/Investor(s) Meeting
DearSir/Madam,
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations,
2015, as amended, we hereby submit schedule of Analyst(s)/Financial Institution(s)/Investor(s) meeting
thattheCompanywouldbeparticipating:
Sr. Date Analyst(s)/Financial Type Mode
No. Institution(s)/Investor(s)
1. 12August 2026 AmbitGlobalPrivate OnetoOneMeeting VirtualMeeting
Client
2. 12August 2026 TAAssociate OnetoOneMeeting VirtualMeeting
Pleasenotethattheaboveissubjecttochange,ifany.
The Company will be referring to publicly available information for discussions during interaction in
themeeting.
Noconfidential/unpublishedpricesensitiveinformation(UPSI)willbesharedduringthemeeting.
The above information shall be made available on the website of the Company at
www.tatvachintan.com.
Kindlytakeaboveintimationonyourrecordandoblige.
Thankingyou,
Yoursfaithfully,
ForTatvaChintanPharmaChemLimited
IshwarNayi
CompanySecretaryandComplianceOfficer
M.No.:A37444